Table 1.
Baseline characteristics at the initial diagnosis of primary breast cancer (n = 75)
| Characteristics | Status | |
|---|---|---|
| Median age (range), years | 50 (27–79) | |
|
n (%) |
||
| Menopausal status | pre | 32 (43) |
| post | 43 (57) | |
| TNM stage | I + II | 1 + 50 (68) |
| (AJCC 7th edition) | III | 24 (32) |
| Tumor size | T ≤ 2 cm | 11 (15) |
| T > 2 cm | 64 (85) | |
| Nodal status | negative | 24 (32) |
| positive | 51 (68) | |
| Lymphovascular invasion | absent | 17 (23) |
| present | 51 (68) | |
| unknown | 7 (9) | |
| Histological grade | grade 1 + 2 | 5 + 26 (41) |
| grade 3 | 44 (59) | |
| Subtypes | luminal A | 13 (17) |
| luminal B | 11 (15) | |
| luminal HER2 | 14 (19) | |
| non-luminal HER2 | 18 (24) | |
| triple negative | 19 (25) | |
| Surgery | mastectomy | 41 (55) |
| conservation | 34 (45) | |
| Neo-/adjuvant treatments | chemotherapy | 54 (72) |
| anthracyclines | 35 (47) | |
| taxanes | 23 (31) | |
| trastuzumab | 7 (9) | |
| endocrine therapy | 32 (43) |